Clindamycin Injection, Solution
Product Images NDC 71872-7284

2 FDA label images from Medical Purchasing Solutions, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 71872-7284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cli04 0016 01)

Structural Formula (Cli04 0016 01)
Chemical structure diagram of clindamycin phosphate, the active ingredient in Clindamycin injection solution. The image shows the molecular arrangement of carbon, hydrogen, oxygen, nitrogen, sulfur, and phosphorus atoms that constitute clindamycin phosphate.*
FDA Label Image

Clinlabel (Clinlabel)

Clinlabel (Clinlabel)
Clindamycin Injection, USP 150 mg/mL solution in a 6 mL single-dose vial. The label includes usage instructions for intramuscular and intravenous routes, storage conditions at 20°C to 25°C, and a dilution warning if given intravenously. Manufactured by Sagent Pharmaceuticals and repackaged by Medical Purchasing Solutions, LLC. Contains clindamycin phosphate equivalent to 150 mg clindamycin per mL with preservatives and buffering agents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.